MALT lymphoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{MALT lymphoma}} | {{MALT lymphoma}} | ||
{{CMG}} | {{CMG}}{{AE}}{{SR}} | ||
==Overview== | ==Overview== | ||
==Medical therapy== | ==Medical therapy== | ||
The various treatment options for MALT lymphoma include: | |||
{{familytree/start |summary=Treatment of MALT lymphoma}} | |||
{{familytree |boxstyle=background: #DCDCDC;| | | | | | | | | | | | | A01| | | | | | | | | | | | | |A01=<div style="width: 12em; padding:0.2em;">'''Treatment of MALT lymphoma'''</div>}} | |||
{{familytree |boxstyle=background: #DCDCDC;| | | | | | | |,|-|-|-|-|-|^|-|-|-|-|-|.| | | | | | | | | | | | | | |}} | |||
{{familytree |boxstyle=background: #DCDCDC;| | | | | | | B01 | | | | | | | | | | B02 | | | | | | | | | | | | | | | |B01=<div style="width: 12em; padding:0em;">'''Early stage<br>(localized)<br>''' </div>|B02=<div style="width: 12em; padding:0em;">'''Advanced stage'''</div>}} | |||
{{familytree |boxstyle=background: #DCDCDC;| | | | | | | F01 | | | | | | | | | | F02 | | | | | | | | | | | | | | | |F01=<div style="width: 12em; padding:0em;">'''WHO grade I / II''' </div>|F02=<div style="width: 12em; padding:0em;">'''WHO grade II'''</div>}} | |||
{{familytree |boxstyle=background: #DCDCDC;| | | | | | | |!| | | | | |,|-|-|-|v|-|^|-|v|-|-|-|.| | | | | | | | | | | | | | |}} | |||
{{familytree |boxstyle=background: #DCDCDC;| | | | | | | |!| | | | | C01 | | C02 | | C03 | | C04 | | | | | | | | | | | | | |C01=<div style="width: 9em; padding:0.2em;">'''[[Fibrillary astrocytoma]]''' </div>|C02=<div style="width: 9em; padding:0.2em;">'''[[Gemistocytic astrocytoma]]'''</div>|C03=<div style="width: 9em; padding:0.2em;">'''[[Protoplasmic astrocytoma]]'''</div>|C04=<div style="width: 9em; padding:0.2em;">'''[[Oligoastrocytoma]]'''</div>}} | |||
{{familytree |boxstyle=background: #DCDCDC;| |,|-|-|-|v|-|^|-|v|-|-|-|.| | | | | | | | | | | | | | | | | |}} | |||
{{familytree |boxstyle=background: #DCDCDC;| D01 | | D02 | | D03 | | D04 | | | | | | | | | | | | | | | | | | | | |D01=<div style="width: 9em; padding:0.2em;">'''[[Pilocytic astrocytoma]]''' </div>|D02=<div style="width: 9em; padding:0.2em;">'''Pilomyxoid astrocytoma'''</div>|D03=<div style="width: 9em; padding:0.2em;">'''[[Subependymal giant cell astrocytoma]]'''</div>|D04=<div style="width: 9em; padding:0.2em;">'''[[Pleomorphic xanthoastrocytoma]]'''</div>}} | |||
{{familytree |boxstyle=background: #DCDCDC;| E01 | | E02 | | E03 | | E04 | | | | | | | | | | | | | | | | | | | | |E01=<div style="width: 9em; padding:0.2em;">'''WHO grade I''' </div>|E02=<div style="width: 9em; padding:0.2em;">'''WHO grade II'''</div>|E03=<div style="width: 9em; padding:0.2em;">'''WHO grade I'''</div>|E04=<div style="width: 9em; padding:0.2em;">'''WHO grade II'''</div>}} | |||
{{familytree/end}} | |||
If the disease is limited to the stomach (which is assessed with [[computed tomography]]), then 70-80% of patients will have a complete regression on treatment with [[antibiotic]] eradication of ''H. pylori''. <ref>{{cite journal | author = Bayerdörffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M | title = Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. | journal = Lancet | volume = 345 | issue = 8965 | pages = 1591-4 | year = 1995 | id = PMID 7783535}}</ref> | If the disease is limited to the stomach (which is assessed with [[computed tomography]]), then 70-80% of patients will have a complete regression on treatment with [[antibiotic]] eradication of ''H. pylori''. <ref>{{cite journal | author = Bayerdörffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M | title = Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. | journal = Lancet | volume = 345 | issue = 8965 | pages = 1591-4 | year = 1995 | id = PMID 7783535}}</ref> | ||
| Line 20: | Line 32: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category: | [[Category:Oncology]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 17:26, 25 January 2016
|
MALT lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
MALT lymphoma medical therapy On the Web |
|
American Roentgen Ray Society Images of MALT lymphoma medical therapy |
|
Risk calculators and risk factors for MALT lymphoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Medical therapy
The various treatment options for MALT lymphoma include:
Treatment of MALT lymphoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Early stage (localized) | Advanced stage | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WHO grade I / II | WHO grade II | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pilomyxoid astrocytoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
WHO grade I | WHO grade II | WHO grade I | WHO grade II | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
If the disease is limited to the stomach (which is assessed with computed tomography), then 70-80% of patients will have a complete regression on treatment with antibiotic eradication of H. pylori. [1]
Radiotherapy
Others may be effectively controlled with the use of radiotherapy, or surgery. Both modalities may be curative in localized disease.
Chemotherapy
In contrast, if the disease has spread or has been refractory on antibiotics, chemotherapy may need to be considered.
References
- ↑ Bayerdörffer E, Neubauer A, Rudolph B, Thiede C, Lehn N, Eidt S, Stolte M (1995). "Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group". Lancet. 345 (8965): 1591–4. PMID 7783535.